Cardiovascular side effects of newer antidepressants

Antony Fernandez, Suji E. Bang, Komandur Srivathsan, W. Victor R. Vieweg

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations


We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)305-309
Number of pages5
JournalAnadolu Kardiyoloji Dergisi
Issue number3
StatePublished - Sep 1 2007


  • Antidepressant drugs
  • Atrial fibrillation
  • Blood pressure
  • Bradycardia
  • Cardiac death
  • Cardiovascular eftects
  • Electrocardiogram
  • Hypertension
  • Hypotension
  • QT interval
  • Tachycardia
  • Ventricular premature beats

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Cardiovascular side effects of newer antidepressants'. Together they form a unique fingerprint.

Cite this